Creatine monohydrate supplementation does not increase muscle strength, lean body mass, or muscle phosphocreatine in patients with myotonic dystrophy type 1.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/14694498
Conclusion of this study
CrM supplementation did not increase any of the outcome measurements except for plasma creatinine concentration (but not creatinine clearance). Thus, CrM supplementation at 5 g daily does not have any effects on muscle strength, body composition, or activities of daily living in patients with DM1, perhaps because of a failure of the supplementation to increase muscle PCr/beta-ATP content.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study